Cargando…

SARS-CoV-2 vaccination for patients with inflammatory bowel disease – Authors' reply

Detalles Bibliográficos
Autores principales:	Alexander, James L, Kennedy, Nicholas A, Lees, Charlie W, Ahmad, Tariq, Powell, Nick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192089/ https://www.ncbi.nlm.nih.gov/pubmed/34119033 http://dx.doi.org/10.1016/S2468-1253(21)00194-1

Ejemplares similares

Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease
por: Alexander, James L, et al.
Publicado: (2021)

SARS-CoV-2 vaccination in immunosuppressed patients with inflammatory bowel disease: should our approach change?
por: Alexander, James L, et al.
Publicado: (2021)

Bell's palsy and SARS-CoV-2 vaccines—an unfolding story – Authors' reply
por: Ozonoff, Al, et al.
Publicado: (2021)

Transmissibility of SARS-CoV-2 among fully vaccinated individuals – Authors' reply
por: Lalvani, Ajit, et al.
Publicado: (2022)

SARS-CoV-2 seroprevalence in Spain – Authors' reply
por: Pollán, Marina, et al.
Publicado: (2020)

Author's Reply
por: Kaeberlein, Matt, et al.
Publicado: (2006)

SARS-CoV-2 infection in conjunctival tissue – Authors' reply
por: Hui, Kenrie PY, et al.
Publicado: (2020)

Neuropathology associated with SARS-CoV-2 infection – Authors' reply
por: von Weyhern, Claus Hann, et al.
Publicado: (2021)

SARS-CoV-2 vaccination for patients with inflammatory bowel disease
por: Garrido, Hannah M Garcia, et al.
Publicado: (2021)

SARS-CoV-2 serological cross-reactivity with autoantibodies – Authors' reply
por: Teng, Jialin, et al.
Publicado: (2021)

Stability of SARS-CoV-2 in different environmental conditions – Authors' reply
por: Chin, Alex W H, et al.
Publicado: (2020)

Transmission of SARS-CoV-2: still up in the air – Authors' reply
por: Greenhalgh, Trisha, et al.
Publicado: (2022)

Practical measures for SARS-CoV-2 infection prevention – Authors' reply
por: Llibre, Josep M, et al.
Publicado: (2022)

SARS-CoV-2 rapid antigen detection tests – Authors' reply
por: Peeling, Rosanna W, et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 in Hong Kong returnees – Authors' reply
por: To, Kelvin Kai-Wang, et al.
Publicado: (2020)

Challenges and issues of SARS-CoV-2 pool testing – Authors' reply
por: Lohse, Stefan, et al.
Publicado: (2020)

ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 – Authors' reply
por: Voysey, Merryn, et al.
Publicado: (2020)

Serological assays for delayed SARS-CoV-2 case identification – Author's reply
por: Pallett, Scott J C, et al.
Publicado: (2020)

Neutrophils as a pallbearer for SARS-CoV-2 disease burden – Authors’ reply
por: Lutter, René, et al.
Publicado: (2021)

Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran – Authors' reply
por: Darvishian, Maryam, et al.
Publicado: (2021)

Unclear conclusions on SARS-CoV-2 elimination versus mitigation – Authors' reply
por: Oliu-Barton, Miquel, et al.
Publicado: (2021)

Association of SARS-CoV-2 renal tropism with acute kidney injury – Authors' reply
por: Braun, Fabian, et al.
Publicado: (2020)

The ability of the neonatal immune response to handle SARS-CoV-2 infection – Authors' reply
por: Gale, Chris, et al.
Publicado: (2021)

Is oropharyngeal sampling a reliable test to detect SARS-CoV-2? – Authors' reply
por: Tsang, Nicole Ngai Yung, et al.
Publicado: (2021)

Misclassification bias in estimating clinical severity of SARS-CoV-2 variants – Authors' reply
por: Nyberg, Tommy, et al.
Publicado: (2022)

SARS-CoV-2 vaccination uptake by patients with inflammatory bowel disease on biological therapy
por: Selim, Rania, et al.
Publicado: (2021)

SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statement
por: Alexander, James L, et al.
Publicado: (2021)

Cellular responses to SARS-CoV-2 vaccination after B-cell depletion: conflicting results from studies – Authors' reply
por: Moor, Matthias B, et al.
Publicado: (2022)

Misuse of SARS-CoV-2 testing in symptomatic health-care staff in the UK – Authors' reply
por: Black, James R M, et al.
Publicado: (2020)

Specificity and cross-reactivity of a test for anti-SARS-CoV-2 antibodies – Authors' reply
por: Iversen, Kasper, et al.
Publicado: (2021)

Authors' Reply
por: Tian, Di, et al.
Publicado: (2022)

An appeal for an objective, open, and transparent scientific debate about the origin of SARS-CoV-2 – Authors' reply
por: Keusch, Gerald T, et al.
Publicado: (2021)

Fulminant Encephalitis Caused by SARS-CoV-2 in a Two-Month-Old Infant: Authors’ Reply
por: Marwa, Abdelbari, et al.
Publicado: (2023)

Determinants of uptake of a third dose of SARS-CoV-2 vaccines in patients with inflammatory bowel disease
por: Wellens, Judith, et al.
Publicado: (2022)

Decrease in uptake of SARS-CoV-2 vaccine in patients with inflammatory bowel disease on intravenous biological therapy
por: Selim, Rania, et al.
Publicado: (2022)

Serological responses to the first four doses of SARS-CoV-2 vaccine in patients with inflammatory bowel disease
por: Quan, Joshua, et al.
Publicado: (2022)

Authors' Reply
por: Bush, Eliot C, et al.
Publicado: (2006)

Authors' Reply
por: van Nimwegen, Erik, et al.
Publicado: (2006)

Authors' Reply
por: Nguyen, Hung D, et al.
Publicado: (2006)

Author’s reply
por: Manikandan, S
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_kgg3di8h0a76i58su3gcpvg7n0